Gilead’s Seladelpar gets European Marketing Authorization for liver disease treatment
Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...
Pound Sterling weakens against US Dollar as investors see Trump tariffs less fearful
The Pound Sterling gains sharply against its major peers after the release of upbeat UK Retail Sales data for January. UK’s ...
US Dollar Index Price Forecast: Tests 106.50 near descending channel's lower boundary
On the downside, the US Dollar Index may test the lower boundary of the descending channel at 106.10, followed by the key psychological level of 106.00. A break below this critical support zone could ...
EURACTIV19h
Harmonisation health technology assessments, a slow roll in right direction
While Health Technology Assessment agencies anticipate that joint efforts and harmonisation will enhance evaluations’ ...
Japanese Yen and Aussie Dollar News: Will BoJ Tighten Again? Inflation, PMI in Focus
Inflation, wage growth, and BoJ rate hike bets fuel gains. Can US PMI data shift USD/JPY direction? Key levels in focus.
Hosted on MSN20h
OCT West Coast 2025: Recruitment and regulation still pain points
While recruitment and regulation are improving, they remain pain points, say speakers at Arena International’s OCT West Coast ...
Le Lézard22h
Gilead's Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis
Gilead Sciences, Inc. today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis (PBC) in ...
AstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge Funds
We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best ...